Knight Therapeutics
(TSX) GUD
Knight Therapeutics Financials at a Glance
Market Cap
$851.92M
Revenue (TTM)
$510.45M
Net Income (TTM)
$5.61M
EPS (TTM)
$0.06
P/E Ratio
149.06
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$8.69
Volume
174,990
Open
$8.38
Price
$8.69
Volume
174,990
Open
$8.38
Previous Close
$8.69
Daily Range
$8.38 - $8.70
52-Week Range
$5.66 - $8.70
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$8.69
Volume
174,990
Open
$8.38
Previous Close
$8.69
Daily Range
$8.38 - $8.70
52-Week Range
$5.66 - $8.70
GUD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Knight Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
830
CEO
Samira Sakhia, MBA
Website
www.gud-knight.comHeadquarters
Montreal, QC H3Z 3B8, CA
GUD Financials
Key Financial Metrics (TTM)
Gross Margin
37%
Operating Margin
3%
Net Income Margin
1%
Return on Equity
71%
Return on Capital
2%
Return on Assets
1%
Earnings Yield
0.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$851.92M
Shares Outstanding
98.03M
Volume
174.99K
Avg. Volume
108.70K
Financials (TTM)
Gross Profit
$150.74M
Operating Income
$2.20M
EBITDA
$54.37M
Operating Cash Flow
$70.30M
Capital Expenditure
$1.91M
Free Cash Flow
$68.40M
Cash & ST Invst.
$95.28M
Total Debt
$77.91M
Knight Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$148.44M
+68.5%
Gross Profit
$54.44M
+56.1%
Gross Margin
36.67%
N/A
Market Cap
$851.92M
N/A
Market Cap/Employee
$1.14M
N/A
Employees
745
N/A
Net Income
$13.17M
+502.7%
EBITDA
$26.77M
+106.9%
Quarterly Fundamentals
Net Cash
$57.52M
-54.7%
Accounts Receivable
$156.61M
+24.8%
Inventory
$141.92M
+1.3%
Long Term Debt
$48.17M
+62.1%
Short Term Debt
$21.61M
-10.8%
Return on Assets
0.52%
N/A
Return on Invested Capital
1.54%
N/A
Free Cash Flow
$37.12M
+119845.2%
Operating Cash Flow
$40.45M
+1002.1%